In our cohort, 72 (61%) patients met these criteria at baseline while 46 (39%) of patients fall into an indeterminate grey area between chronic infection and chronic hepatitis with HBV-DNA levels > 2000 IU/mL and/or ALT levels >1.25. The gene discussed is GPT; the disease is chronic hepatitis.